| Literature DB >> 36225676 |
Ling Chen1, Tingting Ren1, Yun Tan1, Hong Li1.
Abstract
Background: Depression is common psychiatric morbidity in breast cancer survivors, seriously affecting patients' quality of life and mental health. A growing body of research has investigated depression in breast cancer. However, no visual bibliometric analysis was conducted in this field. This study aimed to visualize the literature to identify hotspots and frontiers in research on breast cancer and depression.Entities:
Keywords: bibliometric analysis; breast cancer; co-citation analysis; depression; research hotspots
Year: 2022 PMID: 36225676 PMCID: PMC9549926 DOI: 10.3389/fpsyg.2022.969679
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1The annual publications on depression in breast cancer from 2002 to 2022.
Top 10 productive authors and co-cited authors in the field of depression in breast cancer.
| Rank | Author | Counts | Rank | Co-cited author | Citation |
|---|---|---|---|---|---|
| 1 | Miaskowski | 69 | 1 | Zigmond As | 1,445 |
| 2 | Paul Steven M | 49 | 2 | Bower Julienne | 1,380 |
| 3 | Ganz Patricia | 43 | 3 | Ganz Patricia | 990 |
| 4 | Bower Julienne | 41 | 4 | Carson Le | 763 |
| 5 | Stanto Annette L | 41 | 5 | Spiegel D | 710 |
| 6 | Johansen Christoffer | 38 | 6 | Radloff Ls | 672 |
| 7 | Jacobsen Paul | 37 | 7 | Beck At | 666 |
| 8 | Cooper Bruce | 33 | 8 | Stanton | 620 |
| 9 | Mehnert Anja | 31 | 9 | Watson | 614 |
| 10 | Evine Jon | 30 | 10 | Mitchell | 594 |
Figure 2A visualization network of collaboration between authors on depression in breast cancer.
The main countries, regions, and institutions contributing to publications on depression in breast cancer.
| Rank | Country/region | Counts | Proportion(%) | H-index | Institutions | Counts | Proportion(%) | Citations |
|---|---|---|---|---|---|---|---|---|
| 1 | United States | 2,632 | 35.81% | 221 | Univ Calif Losangeles | 169 | 2.3 | 11,422 |
| 2 | The Peoples Republic Of China | 644 | 8.76% | 75 | Univ Toronto | 144 | 1.96 | 6,990 |
| 3 | England | 479 | 6.52% | 126 | Univ Calif San Francisco | 143 | 1.95 | 5,566 |
| 4 | Australia | 472 | 6.42% | 104 | Mem Sloan Kettering Canc Ctr | 135 | 1.84 | 8,682 |
| 5 | Canada | 471 | 6.41% | 138 | Univ Texas Md Anderson Canc Ctr | 131 | 1.78 | 5,669 |
| 6 | Germany | 439 | 5.97% | 114 | Univ Pittsburgh | 119 | 1.62 | 5,002 |
| 7 | Netherlands | 357 | 4.86% | 102 | Univ Sydney | 106 | 1.44 | 3,887 |
| 8 | South Korea | 267 | 3.63% | 58 | Univ Michigan | 102 | 1.39 | 4,582 |
| 9 | Italy | 235 | 3.20% | 66 | Dana Farber Canc Inst | 99 | 1.35 | 4,619 |
| 10 | Japan | 199 | 2.71% | 64 | Duke Univ | 97 | 1.32 | 4,279 |
Figure 3A visualization network of collaboration between countries and regions.
The top 10 journals related to depression in breast cancer.
| Ranking | Name | Country/region | Number of publication | % of total publication | Impact factor (2020) | H-index (2020) |
|---|---|---|---|---|---|---|
| 1 | Psycho Oncology | United States | 730 | 9.93 | 3.894 | 132 |
| 2 | Supportive Care in Cancer | Germany | 444 | 6.04 | 3.603 | 84 |
| 3 | Journal of Clinical Oncology | United States | 164 | 2.23 | 44.544 | 145 |
| 4 | Cancer | United States | 150 | 2.04 | 6.86 | 90 |
| 5 | Breast Cancer Research and Treatment | United States | 146 | 1.99 | 4.679 | 48 |
| 6 | Cancer Nursing | United States | 146 | 1.99 | 2.592 | 65 |
| 7 | Journal of Pain and Symptom Management | United States | 126 | 1.71 | 3.612 | 66 |
| 8 | BMC Cancer | England | 109 | 1.48 | 4.43 | 42 |
| 9 | European Journal of Cancer Care | England | 103 | 1.40 | 2.52 | 38 |
| 10 | Oncology Nursing Forum | United States | 102 | 1.39 | 2.172 | 56 |
High-frequency keywords in the studies of depression in breast cancer.
| Rank | Keywords | Frequency, n | Percentage, % | Cumulative percentage, % |
|---|---|---|---|---|
| 1 | Breast cancer | 1,570 | 7.2 | 7.2 |
| 2 | Depression | 1,372 | 6.29 | 13.49 |
| 3 | Cancer | 1,315 | 6.03 | 19.52 |
| 4 | Quality of life | 971 | 4.45 | 23.97 |
| 5 | Anxiety | 754 | 3.46 | 27.43 |
| 6 | Oncology | 669 | 3.07 | 30.5 |
| 7 | Fatigue | 386 | 1.77 | 32.27 |
| 8 | Chemotherapy | 266 | 1.22 | 33.49 |
| 9 | Distress | 215 | 0.99 | 34.48 |
| 10 | Psychological distress | 212 | 0.97 | 35.45 |
| 11 | Social support | 199 | 0.91 | 36.36 |
| 12 | Survivor ship | 153 | 0.7 | 37.06 |
| 13 | Breast neoplasms | 147 | 0.67 | 37.73 |
| 14 | Pain | 140 | 0.64 | 38.37 |
| 15 | Coping | 139 | 0.64 | 39.01 |
| 16 | Psycho-oncology | 135 | 0.62 | 39.63 |
| 17 | Exercise | 130 | 0.6 | 40.23 |
| 18 | Stress | 127 | 0.58 | 40.81 |
| 19 | Physical activity | 123 | 0.56 | 41.37 |
| 20 | Cancer survivors | 119 | 0.55 | 41.92 |
| 21 | Meta-analysis | 116 | 0.53 | 42.45 |
| 22 | Systematic review | 108 | 0.5 | 42.95 |
| 23 | Depressive symptoms | 104 | 0.48 | 43.43 |
| 24 | Sleep | 102 | 0.47 | 43.9 |
| 25 | Palliative care | 98 | 0.45 | 44.35 |
| 26 | Inflammation | 94 | 0.43 | 44.78 |
| 27 | Health-related quality of life | 94 | 0.43 | 45.21 |
| 28 | Symptoms | 92 | 0.43 | 45.64 |
| 29 | Mental health | 92 | 0.43 | 46.07 |
| 30 | Randomized controlled trial | 80 | 0.37 | 46.44 |
| 31 | Screening | 80 | 0.37 | 46.81 |
| 32 | Breast cancer survivors | 80 | 0.37 | 47.18 |
| 33 | Prostate cancer | 76 | 0.35 | 47.53 |
| 34 | Insomnia | 74 | 0.34 | 47.87 |
| 35 | Body image | 73 | 0.33 | 48.2 |
| 36 | Radiotherapy | 73 | 0.33 | 48.53 |
| 37 | Menopause | 72 | 0.33 | 48.86 |
| 38 | Neoplasms | 71 | 0.33 | 49.19 |
| 39 | Supportive care | 70 | 0.32 | 49.51 |
| 40 | Cancer-related fatigue | 70 | 0.32 | 49.83 |
| 41 | Survivors | 69 | 0.32 | 50.15 |
| 42 | Cancer survivorship | 68 | 0.31 | 50.46 |
| 43 | Mindfulness | 67 | 0.31 | 50.77 |
| 44 | Survival | 67 | 0.31 | 51.08 |
| 45 | Cytokines | 66 | 0.3 | 51.38 |
| 46 | Cognition | 62 | 0.28 | 51.66 |
| 47 | Lung cancer | 60 | 0.28 | 51.94 |
| 48 | Advanced cancer | 60 | 0.28 | 52.22 |
| 49 | Nursing | 57 | 0.26 | 52.48 |
| 50 | Mastectomy | 57 | 0.26 | 52.74 |
Figure 4Keywords co-occurrence analysis of global research about depression in breast cancer. (A) Network visualization of the keywords; (B) Keywords co-occurrence overlay mapping from 2002 to 2022.
Figure 5The evolution trend of depression in breast cancer from 2002 to 2020.